Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its oncology pipeline. New data from ...

The aforementioned therapies and other drugs like Regeneron’s linvoseltamab are all being tested in pivotal trials as second- or third-line therapies. So, GSK’s window of opportunity with ...

Introduction: Only in recent years has balloon kyphoplasty gained significance in the treatment of vertebral fractures as an adequate minimally invasive vertebral stabilization technique ...

FDA decision expected by July 30, 2025TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S ...

Discover the power of script logos! Learn from top brands, get expert tips, and create your iconic logo. Elevate your brand identity with our guide. Have you ever stared at a logo and felt… something?

Symbols allow logos to communicate ideas and values efficiently. As a visual shorthand, they tap into our collective unconscious and leverage associations we already hold. Clever use of symbolism ...

Every use of the Endorser logo requires prior permission. When using the Endorser logo with permission, please strictly adhere to the guidelines regarding its reproduction, display and spacing as ...

Pre-Market: 8:20:02 a.m. EST ...

Blue Cross Blue Shield of Michigan said it is evaluating any potential updates to the coverage process for Darzalex Faspro and there are no changes at this time.